# Liquidia Corporation (LQDA) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/LQDA
## Company Profile
- Ticker: LQDA
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 89.12 USD
- Market cap: 4900827535.89 USD
- Last updated: 2026-08-05
## Business Overview
### Pulmonary Hypertension Company
Liquidia develops and commercializes therapies for pulmonary hypertension. Its product strategy applies particle-engineering technology to improve the delivery of established medicines.
### YUTREPIA
YUTREPIA is a dry-powder formulation of treprostinil delivered through a compact, low-effort inhaler. It is approved in the United States for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.
### PRINT Technology
The company's PRINT manufacturing platform produces particles with controlled size, shape and composition. Liquidia uses this capability to create inhaled formulations intended to simplify administration and support dose flexibility.
## Why The Stock Is Moving

As of Aug 5, 2026, LQDA closed up 0.84% at $89.12. No new same-company headline was identified in the current news window.

## Future Catalysts

- Liquidia’s catalysts are still centered on YUTREPIA launch execution and any additional regulatory or commercial step around inhaled treprostinil. The market will care about whether the company can keep converting approval into durable adoption in pulmonary hypertension.

## Recent News
- 2026-07-29 12:30 EST — [Liquidia Corporation to Report Second Quarter 2026 Financial Results on August 12, 2026](https://biopharmsignal.com/news/LQDA/liquidia-corporation-to-report-second-quarter-2026-financial-results-on-august-1-13c2e2e8) — Source: Liquidia Corporation
- 2026-06-11 12:30 EST — [Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions](https://biopharmsignal.com/news/LQDA/liquidia-announces-poster-presentations-at-the-pha-2026-international-ph-confere-bceb1ac6) — Source: Liquidia Corporation
- 2026-06-08 12:30 EST — [Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index](https://biopharmsignal.com/news/LQDA/liquidia-corporation-announces-inclusion-in-the-s-p-smallcap-600-index-9947f2fe) — Source: Liquidia Corporation
- 2026-05-27 12:30 EST — [Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/LQDA/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference) — Source: Liquidia Corporation
- 2026-05-11 10:30 EST — [Liquidia Corporation Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/LQDA/liquidia-corporation-reports-first-quarter-2026-financial-results) — Source: Liquidia Corporation